Last update 07 Sep 2023
Ascendis Pharma A/S

Ascendis Pharma A/S

Public Company|
2006|
California, United States|
NASDAQ: ASND

Overview

Tags

Congenital Disorders
Skin and Musculoskeletal Diseases
Endocrinology and Metabolic Disease
Small molecule drug
Hormone
Biological products

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Nervous System Diseases1
Endocrinology and Metabolic Disease3
Neoplasms3
Top 5 Drug TypeCount
Small molecule drug3
Hormone2
Chemical drugs1
Biological products1
Drug conjugates1
Top 5 TargetCount
TLR7 + TLR8(Toll like receptor 7 + Toll like receptor 8)2
GR(Glucocorticoid receptor)1
NPR(Atrial natriuretic peptide receptor)1
IL-2R + TLR7 + TLR8(Interleukin-2 receptor + Toll like receptor 7 + Toll like receptor 8)1
CaSR + PTH1R(Calcium sensing receptor + Parathyroid hormone receptor)1

Pipeline

Pipeline Snapshot as of 24 Sep 2023

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Preclinical
1
1
Phase 1 Clinical
Phase 2 Clinical
3
1
Phase 3 Clinical
NDA/BLA
1
1
Approved
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
Lonapegsomatropin-tcgd
( GR )
Growth hormone deficiency
More
Approved
Palopegteriparatide
( CaSR + PTH1R )
Hypoparathyroidism
More
NDA/BLA
TransCon CNP
( NPR )
Achondroplasia
More
Phase 3 Clinical
TransCon TLR7/8 agonist/TransCon IL-2 beta/gamma(Ascendis Pharma)
( IL-2R + TLR7 + TLR8 )
Melanoma
More
Phase 2 Clinical
TransCon TLR7/8 Agonist(Ascendis Pharma)
( TLR7 + TLR8 )
Locally Advanced Head and Neck Squamous Cell Carcinoma
More
Phase 2 Clinical
Login to view more data

Profit

Explore the financial positions of over 360K organizations with Synapse.
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
Unearth financing trends to validate and advance investment opportunities.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.